In order to investigate the expression levels of HIF-1α in tissues from patients with CKD, we have used immunohistochemistry to analyze archival, paraffin-embedded renal biopsy material from patients with different stages of diabetic nephropathy, which is the leading cause of end stage renal disease. Here, HIF1A is linked to diabetic kidney disease.